<産業資料/調査レポートの題名> 2022年4月19日

DNAシーケンスの世界市場2020-2024


◆英文タイトル:Global DNA Sequencing Market 2020-2024

01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
1. 2.1 Preface
2. 2.2 Currency conversion rates for US$
03: MARKET LANDSCAPE
3. Market ecosystem
4. Market characteristics
5. Market segmentation analysis
6. Value chain analysis
04: MARKET SIZING
7. Market definition
8. Market sizing 2019
9. Market outlook
10. Market size and forecast 2019-2024
05: FIVE FORCES ANALYSIS
11. Bargaining power of buyers
12. Bargaining power of suppliers
13. Threat of new entrants
14. Threat of substitutes
15. Threat of rivalry
16. Market condition
06: MARKET SEGMENTATION BY SOLUTION
17. Market segmentation by solution
18. Comparison by solution
19. Products – Market size and forecast 2019-2024
20. Services – Market size and forecast 2019-2024
21. Market opportunity by solution
07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
22. Geographic segmentation
23. Geographic comparison
24. North America – Market size and forecast 2019-2024
25. Europe – Market size and forecast 2019-2024
26. Asia – Market size and forecast 2019-2024
27. ROW – Market size and forecast 2019-2024
28. Key leading countries
29. Market opportunity
09: DECISION FRAMEWORK
10: DRIVERS AND CHALLENGES
30. Market drivers
31. Market challenges
11: MARKET TRENDS
32. Emergence of third-generation sequencing methods
33. Development of sophisticated bioinformatics tools for NGS
34. Automation of DNA Sequencing
12: VENDOR LANDSCAPE
35. Overview
36. Landscape disruption
37. Competitive scenario
13: VENDOR ANALYSIS
38. Vendors covered
39. Vendor classification
40. Market positioning of vendors
41. Agilent Technologies Inc.
42. BGI Genomics Co. Ltd.
43. Bio-Rad Laboratories Inc.
44. Danaher Corp.
45. Eurofins Scientific SE
46. F. Hoffmann-La Roche Ltd.
47. Illumina Inc.
48. PerkinElmer Inc.
49. QIAGEN NV
50. Thermo Fisher Scientific Inc.
14: APPENDIX
51. Research methodology
52. List of abbreviations
53. Definition of market positioning of vendors
15: EXPLORE TECHNAVIO


Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Solution – Market share 2019-2024 (%)
Exhibit 19: Comparison by solution
Exhibit 20: Products – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Products – Year-over-year growth 2020-2024 (%)
Exhibit 22: Services – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Services – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by solution
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Agilent Technologies Inc. – Vendor overview
Exhibit 45: Agilent Technologies Inc. – Business segments
Exhibit 46: Agilent Technologies Inc. – Organizational developments
Exhibit 47: Agilent Technologies Inc. – Geographic focus
Exhibit 48: Agilent Technologies Inc. – Segment focus
Exhibit 49: Agilent Technologies Inc. – Key offerings
Exhibit 50: BGI Genomics Co. Ltd. – Vendor overview
Exhibit 51: BGI Genomics Co. Ltd. – Service segments
Exhibit 52: BGI Genomics Co. Ltd. – Organizational developments
Exhibit 53: BGI Genomics Co. Ltd. – Key offerings
Exhibit 54: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 55: Bio-Rad Laboratories Inc. – Business segments
Exhibit 56: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 57: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 58: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 59: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 60: Danaher Corp. – Vendor overview
Exhibit 61: Danaher Corp. – Business segments
Exhibit 62: Danaher Corp. – Organizational developments
Exhibit 63: Danaher Corp. – Geographic focus
Exhibit 64: Danaher Corp. – Segment focus
Exhibit 65: Danaher Corp. – Key offerings
Exhibit 66: Eurofins Scientific SE – Vendor overview
Exhibit 67: Eurofins Scientific SE – Business segments
Exhibit 68: Eurofins Scientific SE – Organizational developments
Exhibit 69: Eurofins Scientific SE – Segment focus
Exhibit 70: Eurofins Scientific SE – Key offerings
Exhibit 71: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 72: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 73: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 74: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 75: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 76: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 77: Illumina Inc. – Vendor overview
Exhibit 78: Illumina Inc. – Business segments
Exhibit 79: Illumina Inc. – Organizational developments
Exhibit 80: Illumina Inc. – Geographic focus
Exhibit 81: Illumina Inc. – Segment focus
Exhibit 82: Illumina Inc. – Key offerings
Exhibit 83: PerkinElmer Inc. – Vendor overview
Exhibit 84: PerkinElmer Inc. – Business segments
Exhibit 85: PerkinElmer Inc. – Organizational developments
Exhibit 86: PerkinElmer Inc. – Geographic focus
Exhibit 87: PerkinElmer Inc. – Segment focus
Exhibit 88: PerkinElmer Inc. – Key offerings
Exhibit 89: QIAGEN NV – Vendor overview
Exhibit 90: QIAGEN NV – Business segments
Exhibit 91: QIAGEN NV – Organizational developments
Exhibit 92: QIAGEN NV – Geographic focus
Exhibit 93: QIAGEN NV – Segment focus
Exhibit 94: QIAGEN NV – Key offerings
Exhibit 95: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 96: Thermo Fisher Scientific Inc. – Business segments
Exhibit 97: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 98: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 99: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 100: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 101: Validation techniques employed for market sizing
Exhibit 102: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark